Anthropometry (2)
- HEIGHT - Height measured at enrollment (phv00423978.v1.p1)
- WEIGHT - Subject's weight (phv00423977.v1.p1)
Biomarkers (17)
- ANC - Absolute neutrophil count (ANC) (phv00423985.v1.p1)
- ARC - Absolute Reticulocyte Counts (phv00423995.v1.p1)
- BUN - Blood urea nitrogen (phv00424008.v1.p1)
- CREATININE - Serum creatinine level (phv00424007.v1.p1)
- DBP - Diastolic blood pressue (phv00423975.v1.p1)
- HEMATOCRIT - Percentage of red blood cells by volume in the blood (phv00423989.v1.p1)
- HEMOGLOBIN - Hemoglobin (phv00423988.v1.p1)
- LDH - Lactate dehydrogenase (phv00424009.v1.p1)
- MCH - Mean corpuscular hemoglobin (phv00423991.v1.p1)
- MCHC - Mean corpuscular hemoglobin concentration (phv00423992.v1.p1)
- MCV - Mean corpuscular volume (phv00423990.v1.p1)
- PLATELET - Platelet Count (phv00423993.v1.p1)
- RBC - Red Blood Cell Count (phv00423986.v1.p1)
- RDW - Red cell Distribution Width (phv00423987.v1.p1)
- SBP - Systolic blood pressue (phv00423974.v1.p1)
- T_BILI - Total Bilirubin (phv00424010.v1.p1)
- WBC - White Blood Cell Count (phv00423984.v1.p1)
Demographics (3)
- AGE - Subject age (phv00423972.v1.p1)
- GENDER - Gender of participant (phv00423973.v1.p1)
- SEX - Sex of Subject (phv00556618.v1.p1)
Disease Events (9)
- ACS - Acute Chest Syndrome (phv00424031.v1.p1)
- ASTHMA - Asthma or wheezing (phv00424036.v1.p1)
- GALLBLADDER - Gallbladder disease (phv00424039.v1.p1)
- KIDNEY_DISEASE - Kidney disease or renal insufficiency (phv00424038.v1.p1)
- LEG_ULCERS - Leg ulcers (phv00424034.v1.p1)
- PRIAPISM - Painful erections (phv00424035.v1.p1)
- STROKE_6_MONTHS - Stroke history in past 6 months (phv00424027.v1.p1)
- STROKE_HISTORY - Stroke history (phv00424026.v1.p1)
- STROKE_SILENT - Silent Cerebral Infarction in past 6 months (phv00424028.v1.p1)
General Health (6)
- AVN_HIP - Avascular Necrosis/Osteonecrosis_Hip (phv00424032.v1.p1)
- AVN_SHOULDER - Avascular Necrosis/Osteonecrosis_Shoulder (phv00424033.v1.p1)
- HOSPITAL_6_MONTHS - Number of hospital admissions in past 6 months (phv00424029.v1.p1)
- RETINOPATHY - Eye problem or retinal disease (phv00424037.v1.p1)
- SPLENEC_TOMY - Splenectomy surgery (phv00424040.v1.p1)
- VOE_6_MONTHS - Number of pain crisis (Vaso-occlusive episodes) requiring ER or Doctor visit in past 6 months (phv00424030.v1.p1)
Medications (1)
- CHRONIC_PAIN - Chronic pain _6 months or more of pain (phv00424025.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Ethnicity group of participant (phv00423982.v1.p1)
- RACE - Racial category of participant (phv00423981.v1.p1)
Reproductive Health (1)
- PREGNANCY - Number of pregnancies (phv00423979.v1.p1)
Respiratory (4)
- DLCO_ADJUSTED - Hemoglobin adjusted diffusing capacity for carbon monoxide (phv00424021.v1.p1)
- PFT_FEV1 - Pulmonary function test_forced expiratory volume in one second (FEV1) (phv00424019.v1.p1)
- PFT_FVC - Pulmonary function test_forced vital capacity (FVC) (phv00424018.v1.p1)
- PFT_TLC - Pulmonary function test_Total Lung Capacity (phv00424020.v1.p1)
Sleep (1)
- O2 - Oxygen saturation (phv00423976.v1.p1)
Substance Use (1)
- SMOKING - Tobacco use history of participant - current smoking status (phv00423980.v1.p1)
Other (37)
- ANALYTE_TYPE - Analyte Type (phv00424043.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00424042.v1.p1)
- CHRONIC_RBC - Is the participant on a chronic red blood cell transfusion program (phv00424023.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00423967.v1.p1)
- ECHO_TRV - Echocardiography_Tricuspid Regurgitation Velocity (phv00424013.v1.p1)
- EDUCATION - Level of education (phv00423983.v1.p1)
- FERRITIN - Serum ferritin level (phv00424011.v1.p1)
- Funding_Source - Project funding source (phv00424046.v1.p1)
- HB_F - Fetal hemoglobin/total hemoglobin. (phv00423996.v1.p1)
- HBA1_HPLC - Hemoglobin A1_high-performance liquid chromatography (phv00424005.v1.p1)
- HBA2_HPLC - Hemoglobin A2_high-performance liquid chromatography (phv00424006.v1.p1)
- HBC_HPLC - Hemoglobin C_high-performance liquid chromatography (phv00424003.v1.p1)
- HBF_HPLC - Hemoglobin F_high-performance liquid chromatography (phv00424004.v1.p1)
- HBS_HPLC - Hemoglobin S_high-performance liquid chromatography (phv00424002.v1.p1)
- HGBA1_EP - Hemoglobin A1_Electrophoresis (phv00424000.v1.p1)
- HGBA2_EP - Hemoglobin A2_Electrophoresis (phv00424001.v1.p1)
- HGBC_EP - Hemoglobin C_Electrophoresis (phv00423998.v1.p1)
- HGBF_EP - Hemoglobin F_Electrophoresis (phv00423999.v1.p1)
- HGBS_EP - Hemoglobin S_Electrophoresis (phv00423997.v1.p1)
- HU - Hydroxyurea treatment (phv00424024.v1.p1)
- IS_TUMOR - Tumor status (phv00424044.v1.p1)
- LIFETIME_RBC - Total number of red blood cell transfusion in lifetime (phv00424022.v1.p1)
- RETIC_PERCENTAGE - Percentage of reticulocytes in the blood (phv00423994.v1.p1)
- SAMPLE_ID - Sample ID (phv00424041.v1.p1)
- SAMPLE_ID - Sample ID (phv00423970.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00424045.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00424049.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00423971.v1.p1)
- SUBJECT_ID - Subject ID (phv00423966.v1.p1)
- SUBJECT_ID - Subject ID (phv00423969.v1.p1)
- TCD_LEFTICA - Transcranial Doppler_Left Internal Carotid Arteries (phv00424017.v1.p1)
- TCD_LEFTMCA - Transcranial Doppler_Left Middle Cerebral Arteries (phv00424015.v1.p1)
- TCD_RIGHTICA - Transcranial Doppler_Right Internal Carotid Arteries (phv00424016.v1.p1)
- TCD_RIGHTMCA - Transcranial Doppler_Right Middle Cerebral Arteries (phv00424014.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00424047.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00424048.v1.p1)
- TRANSFERRIN - Serum transferrin level (phv00424012.v1.p1)